Contact us
Menu
Contact us

News

Feldan News

16 June, 2020

Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on its intracellular delivery technology, today announced the appointment of Dr. Robert …

Read More

28 October, 2019

Dr. Paul McCray (University of Iowa) and Feldan Therapeutics enable protein and CRISPR nuclease delivery to cultured human well-differentiated airway epithelial cells and in vivo using the Feldan Shuttle technology …

Read More

14 June, 2019

On June 13th 2019, Anges Québec celebrated its 10th anniversary as part of the annual Rendez-vous 2019, the event that brings together angel investors, portfolio companies, venture capital ecosystem players …

Read More

4 June, 2019

Philadelphia, June 4th, 2019 – CQDM is pleased to announce that following their recent enrollment in the consortium, Amgen and Takeda will be joining the syndicate of pharma companies to …

Read More

8 February, 2019

Feldan Therapeutics is proud to unveil its new corporate identity! This new visual highlights the company's commitment to the therapeutic development of the Feldan Shuttle technology, an innovation developed in-house …

Read More

5 December, 2018

Congratulations to Francois-Thomas Michaud for winning the “Visionary Entrepreneur of the Year” Award given by the CCIQ Chambre de commerce et d’industrie de Québec. Congratulations to Feldan Therapeutics’s team for its contribution to the success …

Read More

27 November, 2018

Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, has announced an investment of …

Read More

14 November, 2018

We are proud partner of the CRISPR congress 2019 to be held in Québec City, June 17-20, 2019. This annual event provides an international forum for scientists and organizations interested …

Read More

12 October, 2018

Quebec City, Canada, October 12, 2018 – David Guay, Research Director of Feldan Therapeutics (hereafter “Feldan”) announced that his collaborator, Dr. Paul McCray from the University of Iowa Carver College …

Read More

18 September, 2018

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions Series A financing round led by GC (parent company of GC Pharma), with the …

Read More